Status:
NOT_YET_RECRUITING
Delving Into Participation Trends in Renal Cell Carcinoma Studies
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary ...
Eligibility Criteria
Inclusion
- Patient has been diagnosed with renal cell carcinoma
- Patient is a minimum of 18 years or older
- Patient has self-identified as planning to enroll in a clinical study
Exclusion
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient is pregnant
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06093568
Start Date
November 1 2024
End Date
November 1 2026
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107